SPACE · SpaceX launches classified USSF-481 for Space Force
A secret Space Force payload rode a Falcon 9 into orbit from Vandenberg, with SpaceX staying silent on what it's carrying.
@thedailyfathom.bsky.social
@thedailyfathom.bsky.socialSPACE · SpaceX launches classified USSF-481 for Space Force
A secret Space Force payload rode a Falcon 9 into orbit from Vandenberg, with SpaceX staying silent on what it's carrying.
@thedailyfathom.bsky.socialENERGY · FERC proposes blanket approvals for LNG, gas projects
The energy regulator voted Oct. 15 to speed up permits for gas projects and loosen how it reviews their air-quality impact.
@thedailyfathom.bsky.socialBIOTECH · AstraZeneca pays insitro $40M for AI drug deal
The deal could reach $1.5 billion as insitro's AI hunts for new drug targets in liver and heart disease.
@thedailyfathom.bsky.socialCRYPTO · Brooklyn DA takes down 112-server crypto scam network
Brooklyn prosecutors and the FBI seized 112 servers and 241 fake websites used to steal tens of millions from Russian-speaking victims.
@thedailyfathom.bsky.socialAI · 8 states sue OpenAI over ChatGPT's harm to kids
Eight states accuse OpenAI of breaking consumer protection laws, saying ChatGPT hurt children and deceived adults who trusted it.
@thedailyfathom.bsky.socialENERGY · Tesla finally unveils its new Roadster tonight
After nearly nine years of delays, Tesla will reveal its next Roadster today — and try to settle whether it can actually fly.
@thedailyfathom.bsky.socialBIOTECH · Colossal's new AI hunts for dodo gene-editing targets
The de-extinction company's new AI platform, GenoMorph, flagged about 2,300 genes that could help recreate dodo traits in a living relative.
@thedailyfathom.bsky.socialCRYPTO · Bitcoin falls below $81K as nearly $1B gets liquidated
A hot inflation report revived fears of another Fed rate hike, triggering a crypto-wide selloff that forced nearly $1 billion in bets to close.
@thedailyfathom.bsky.socialAI · Anthropic's revenue hit $16.8B before its IPO
Anthropic told investors its revenue jumped 45% to $16.8 billion last quarter, a signal of strength as it prepares to go public.
@thedailyfathom.bsky.socialSPACE · NASA's Perseverance rover sets a Mars driving record
The rover drove past the distance record set by NASA's earlier rover, Opportunity, with years of exploring still ahead.
@thedailyfathom.bsky.socialBIOTECH · BioNTech's cancer vaccine misses key trial goal
The mRNA shot failed to slow tumor growth in a head-and-neck cancer trial, BioNTech's third mRNA setback this year.
@thedailyfathom.bsky.socialCRYPTO · Binance is shutting down its Bitcoin mining pool
The exchange is closing mining pool, cloud mining, and related services on Nov. 10, after six years.
@thedailyfathom.bsky.socialAI · FBI arrests OpenAI employee over hidden listening device
A Saudi national working at OpenAI secretly planted a recording device in an executive conference room, and the FBI arrested him this week.
@thedailyfathom.bsky.socialSPACE · NASA, SpaceX launch ISS's last new solar arrays today
A Falcon 9 carries the space station's final roll-out solar arrays and 6,300 pounds of supplies, finishing a years-long power upgrade.
@thedailyfathom.bsky.socialENERGY · Fervo's next-gen geothermal plant just went commercial
Fervo Energy's Cape Station in Utah is the first enhanced geothermal project in the world to start selling power commercially.
@thedailyfathom.bsky.socialBIOTECH · Bristol Myers' lung drug works at low dose, fails at high
A key lung-scarring drug succeeded at 60mg but missed at 120mg, while a second trial slowed a rare tumor's growth.
@thedailyfathom.bsky.socialCRYPTO · South Korean bank now lets you borrow cash on your Bitcoin
Jeonbuk Bank is South Korea's first bank to accept Bitcoin as collateral for business loans, without ever holding the coins itself.
@thedailyfathom.bsky.socialAI · Meta launches its first frontier AI model, Muse Wonder
Meta's new Muse Wonder models are its first real shot at competing with OpenAI's ChatGPT and Anthropic's Claude.
@thedailyfathom.bsky.socialBIOTECH · AstraZeneca's bone disease drug fails late-stage trial
Efzimfotase alfa missed its goal in a rare bone disease trial. AstraZeneca blames the study's design, not the drug.
@thedailyfathom.bsky.socialCRYPTO · Bitcoin slides as 10-year Treasury yield hits 5.3%
Rising government bond yields are pulling money out of Bitcoin, now down roughly a third from its record high.